AI English summary of an SEC filing — figures as filed
Stryker SYKStryker said it entered into a merger agreement to acquire all outstanding shares of Inari Medical, Inc. for $80.00 per share in cash on January 6, 2025. The company said the total fully diluted equity value is about $4.9 billion.
Key points
AI summaryStryker said it entered into a merger agreement to acquire all outstanding shares of Inari Medical, Inc. for $80.00 per share in cash on January 6, 2025. The company said the total fully diluted equity value is about $4.9 billion.
Stryker said it will launch a tender offer through Merger Sub and then merge Inari into the company. Completion of the tender offer is subject to the satisfaction or waiver of a minimum tender condition of a majority of shares, the expiration or termination of the Hart-Scott-Rodino waiting period, and the absence of legal restraints.
The company said the tender offer will initially remain open for a minimum of 20 business days from its commencement date. It said the merger agreement can be terminated if the acceptance time has not occurred by July 7, 2025, and that the end date will be automatically extended to October 6, 2025 under certain conditions.
The company said Inari will pay a termination fee of $163 million to Stryker in certain circumstances, including if Inari terminates the agreement to accept a superior proposal or if Stryker terminates because Inari's board changed its recommendation. The company said it expects the transaction to close by the end of Q1 2025.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Stryker to Acquire Inari Medical for $80.00 per Share in Cash
Stryker said it entered into a merger agreement to acquire all outstanding shares of Inari Medical, Inc. for $80.00 per share in cash on January 6, 2025. The company said the total fully diluted equity value is about $4.9 billion.
Source · Based on the filing body and exhibits
Tender Offer and Merger Structure and Closing Conditions
Stryker said it will launch a tender offer through Merger Sub and then merge Inari into the company. Completion of the tender offer is subject to the satisfaction or waiver of a minimum tender condition of a majority of shares, the expiration or termination of the Hart-Scott-Rodino waiting period, and the absence of legal restraints.
Source · Based on the filing body and exhibits
Tender Offer Period and Agreement End Date
The company said the tender offer will initially remain open for a minimum of 20 business days from its commencement date. It said the merger agreement can be terminated if the acceptance time has not occurred by July 7, 2025, and that the end date will be automatically extended to October 6, 2025 under certain conditions.
Source · Based on the filing body and exhibits
$163 million Termination Fee and Closing Timing
The company said Inari will pay a termination fee of $163 million to Stryker in certain circumstances, including if Inari terminates the agreement to accept a superior proposal or if Stryker terminates because Inari's board changed its recommendation. The company said it expects the transaction to close by the end of Q1 2025.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…